EHA2023 Hybrid Congress
Meet us at the EHA2023 Hybrid Congress (June, 8 – 11, 2023) in Frankfurt, Germany.
Single cell sequencing has the power to accelerate and promote novel therapies from bench to bedside by unravelling the underlying mechanisms of complex, heterogenous diseases at single cell resolution. Are you interested in learning more about how single cell sequencing can impact your research project? Get in touch and talk to our colleagues, Dr. Andreas Schmidt (SVP of Global Business Development) and Dr. Regina Ohmer (Key Account Manager) at the EHA2023 to learn more about Singleron’s innovative single cell multi-omics sequencing solutions.
In order to support and accelerate crucial research into the underlying mechanisms of hematological disorders, especially in the pathogenesis of multiple myeloma, Singleron is proud to be a sustaining member of the German Speaking Myeloma Multicenter Group (GMMG).
We look forward to meeting you in Frankfurt!
If you would like to set up a meeting at the EHA2023, please contact us via email.
Copyright © 2023 Singleron Biotechnologies